The common denominators of Parkinson's disease pathogenesis and methamphetamine abuse
B Vincent, M Shukla - Current Neuropharmacology, 2023 - hal.science
The pervasiveness and mortality associated with methamphetamine abuse has doubled
during the past decade suggesting a possible worldwide substance use crisis. Epitomizing …
during the past decade suggesting a possible worldwide substance use crisis. Epitomizing …
Methamphetamine-induced neurotoxicity: the road to Parkinson's disease
B Thrash, K Thiruchelvan, M Ahuja… - Pharmacological …, 2009 - Elsevier
Studies have implicated methamphetamine exposure as a contributor to the development of
Parkinson's disease. There is a significant degree of striatal dopamine depletion produced …
Parkinson's disease. There is a significant degree of striatal dopamine depletion produced …
Is methamphetamine abuse a risk factor in parkinsonism?
TR Guilarte - Neurotoxicology, 2001 - Elsevier
Parkinson's disease (PD) is a neurodegenerative disorder with increased incidence in
individuals beyond 50 years of age. The etiology of PD is currently not known, but it appears …
individuals beyond 50 years of age. The etiology of PD is currently not known, but it appears …
Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining
S Ares-Santos, N Granado, I Espadas… - …, 2014 - nature.com
Methamphetamine is a widely abused illicit drug. Recent epidemiological studies showed
that methamphetamine increases the risk for developing Parkinson's disease (PD) in …
that methamphetamine increases the risk for developing Parkinson's disease (PD) in …
Methamphetamine and Parkinson′ s Disease
N Granado, S Ares-Santos, R Moratalla - Parkinson's disease, 2013 - Wiley Online Library
Parkinson′ s disease (PD) is a neurodegenerative disorder predominantly affecting the
elderly. The aetiology of the disease is not known, but age and environmental factors play …
elderly. The aetiology of the disease is not known, but age and environmental factors play …
Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse
Parkinson disease (PD) is a chronic and progressive neurological disease associated with a
loss of dopaminergic neurons. In most cases the disease is sporadic but genetically …
loss of dopaminergic neurons. In most cases the disease is sporadic but genetically …
Neuroprotection or neurotoxicity of illicit drugs on Parkinson's disease
Parkinson's Disease (PD) is currently the most rapid growing neurodegenerative disease
and over the past generation, its global burden has more than doubled. The onset of PD can …
and over the past generation, its global burden has more than doubled. The onset of PD can …
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of …
Parkinson disease (PD) is a chronic and progressive neurological disease associated with a
loss of dopaminergic neurons. In most cases the disease is sporadic but genetically …
loss of dopaminergic neurons. In most cases the disease is sporadic but genetically …
The methamphetamine experience: a NIDA partnership
GR Hanson, KS Rau, AE Fleckenstein - Neuropharmacology, 2004 - Elsevier
The neurotoxic properties of the amphetamines such as methamphetamine (METH) were
originally described about the time of the National Institute on Drug Abuse's organization, in …
originally described about the time of the National Institute on Drug Abuse's organization, in …
The role of α-synuclein in methamphetamine-induced neurotoxicity
M Wu, H Su, M Zhao - Neurotoxicity Research, 2021 - Springer
Methamphetamine (METH), a highly addictive psychostimulant, is the second most widely
used illicit drug. METH produces damage dopamine neurons and apoptosis via multiple …
used illicit drug. METH produces damage dopamine neurons and apoptosis via multiple …